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To quantify the effect of different methodological decisions on the identification of potential 38 
core outcomes to inform the development of recommendations. 39 
Design 40 
Mixed methods study. 41 
Setting 42 
A core outcome set for pre-eclampsia was used as an exemplar. 43 
Sample 44 
A long list of potential core outcomes was developed by undertaking a systematic review of 45 
pre-eclampsia trials and performing a thematic analysis of in-depth patient interviews. 46 
Methods 47 
Specific methods used to generate long lists of potential core outcomes were evaluated, 48 
including limitations placed within the search strategy and varied approaches in the 49 
extraction of outcomes from published trial reports. 50 
Results 51 
Different methodological decisions had a substantial impact on the identification of potential 52 
core outcomes. Extracting outcomes from published pre-eclampsia trials was an effective 53 
way of identifying 48 maternal, eight fetal, 25 neonatal outcomes, and eight patient-reported 54 
outcomes. Limiting the extraction of outcomes to primary outcomes or outcomes commonly 55 
reported in pre-eclampsia trials reduced the number and diversity of potential core outcomes 56 
identified. Thematic analysis of in-depth patient interviews ensured an additional five patient 57 
reported outcomes and six outcomes related to future child health were identified. 58 
Conclusions 59 
Future core outcome set developers should use quantitative and qualitative methods when 60 
developing a long list of potential core outcomes. 61 
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Clinical research should ultimately improve patient care.1 The ability of randomised 84 
controlled trials to inform clinical practice can be limited by several issues including the 85 
failure to consider the perspectives of patients when selecting outcomes, variations in 86 
outcome measures, and outcome reporting bias.2, 3 Problems with poor outcome selection, 87 
measurement, and reporting can be addressed by developing core outcome sets to 88 
standardise outcome selection, collection, and reporting across a specific disease area.4, 5 89 
Over sixty core outcome sets are being developed across ours speciality, including twin-twin 90 
transfusion syndrome, selective fetal growth restriction, and neonatal medicine.6-11  91 
 92 
Core outcome sets are developed in three stages (Figure 1).12 The first step is to develop a 93 
long list of potential core outcomes by undertaking a systematic review of published 94 
randomised controlled trials. A minority of core outcome set studies have also used 95 
qualitative methods, for example in-depth patient interviews.12 The next step is to reduce the 96 
long list of potential core outcomes to a core outcome set using formal consensus methods, 97 
including the modified Delphi method. The final step is to determine how the core outcomes 98 
should be defined and measured. 99 
 100 
As there is considerable uncertainty in core outcome set development methods, we 101 
undertook a systematic review of registered, ongoing, and completed core outcome sets 102 
relevant to women’s and newborn health.13 When delineating the specific methods used to 103 
generate a long list of potential core outcomes, there was considerable variation in the 104 
electronic bibliographical databases searched, differences in the limitations placed within the 105 
search strategy, including publication date, study size, and study design, and varied 106 
approaches in the extraction of outcomes from randomised trial reports. In addition to this 107 
heterogeneity in methodology, no examples were found of the use of qualitative research to 108 
capture patient views regarding potential core outcomes. 109 
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Understanding the most effective methods to use in this emerging field is important in order 110 
to reduce waste and unnecessary delays in the outcome set development process and to 111 
ensure a comprehensive approach is taken. The objective of this study was to quantify the 112 
effect of different methodological decisions on the identification of potential core outcomes to 113 
inform the development of specific recommendations for future core outcome set 114 
developers. A core outcome set for pre-eclampsia was used as an exemplar.14  115 
 116 
Methods 117 
The specific range of methods previously used to generate long lists of potential core 118 
outcomes were extracted from our systematic review of core outcome set development 119 
studies relevant to women’s and newborn health.6 These included differences in the 120 
limitations placed within the search strategy, including publication date, study size, and 121 
methodological quality, and varied approaches in the extraction of outcomes from 122 
randomised trial reports.  123 
 124 
The impact of such methodological decisions was then explored using a systematic review 125 
of published pre-eclampsia trials and in-depth interviews, previously used for capturing 126 
potential core outcomes in pre-eclampsia. Detailed methods have been published elsewhere 127 
for each of the two underlying studies.15-18 128 
 129 
Primary outcomes, secondary outcomes, along with study characteristics, were extracted 130 
from the systematic review.15, 18 Primary outcomes were identified if they were explicitly 131 
stated or if an outcome was included in the study’s power calculation.16 Thematic analysis of 132 
thirty in-depth interviews with women with lived experience of pre-eclampsia was undertaken 133 
identified a further potential core outcome.17 To facilitate comparisons, both sets of 134 
outcomes were organised within a standardised taxonomy (Figure 2). 135 
 136 
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Specific methodological decisions pertinent to the identification of potential core outcomes 137 
were explored in this study, including: 138 
▪ No limitations placed within the search strategy, inclusion criteria, and all outcomes 139 
extracted from published trial reports. 140 
▪ Limitations placed within the search strategy, including: 141 
1. Date limitation from 2007 onwards;  142 
2. Larger trials reporting data from more than 100 participants; and  143 
3. Trials assessed as higher methodological quality, defined as trials fulfilling the Jadad 144 
criteria.19  145 
▪ Different approaches in the extraction of outcomes from study reports, including 146 
1. Primary outcomes; and  147 
2. Commonly reported secondary outcomes, defined as a secondary outcome reported 148 
in three or more trials. 149 
▪ Outcomes identified by thematic analysis of in-depth interviews with women with lived 150 
experience of pre-eclampsia.  151 
 152 
Descriptive tables formally quantified the effect of different methodological decisions on the 153 
identification of potential core outcomes (Figure 3). 154 
 155 
Patients were not involved in the development of this research study. This is independent 156 
research arising from a doctoral fellowship (DRF-2014-07-051) supported by the National 157 
Institute for Health Research, awarded following external peer review. The funder had no 158 
role in the study design, data collection and analysis, decision to publish, or preparation of 159 








Seventy-nine pre-eclampsia trials reported 106 different outcomes and thematic analysis of 165 
30 in-depth interviews with women with lived experience of pre-eclampsia identified 71 166 
outcomes (Figure 2). Combining these resulted in one hundred and sixteen unique 167 
outcomes organised within a single standardised taxonomy. The impact of seven different 168 
methodological decisions were examined across seven outcome domains, including: 169 
▪ Mortality; 170 
▪ Maternal outcomes; 171 
▪ Patient reported outcomes; 172 
▪ Fetal outcomes; 173 
▪ Neonatal outcomes; 174 
▪ Childhood outcomes; and 175 
▪ Resource utilisation. 176 
 177 
Maternal, fetal, neonatal, and childhood mortality 178 
Different methodological decisions had no impact on the identification of maternal, fetal, or 179 
neonatal mortality as potential core outcomes (Figure S1). When only primary outcomes 180 
were extracted, neonatal and childhood mortality would not have been identified as a 181 
potential core outcome. 182 
 183 
Maternal outcomes 184 
The methodology used made a substantial difference in the number and diversity of 185 
maternal outcomes identified (Figure S2). Considering the results of the systematic review, 186 
when no limitations were placed within the search strategy, inclusion criteria, or outcome 187 
extraction, 48 maternal outcomes were identified. Limiting the search strategy reduced this 188 
to between 15 and 44 outcomes depending on the decision made. Important domains were 189 
not captured by some strategies, especially when the search was limited to primary 190 
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outcomes (gastrointestinal and neurological morbidity). Thematic analysis of in-depth patient 191 
interviews identified 24 maternal outcomes, a single domain, cardiovascular morbidity, was 192 
not represented. 193 
 194 
Patient reported outcome  195 
Patient reported outcome asses the patients’ views of their health states, perceived level of 196 
impairment, disability, and health-related quality of life.20 Considering the results of the 197 
systematic review, when no limitations were placed within the search strategy, inclusion 198 
criteria, or outcome extraction, five patient-reported outcomes were identified (Figure S3). 199 
Limiting the search strategy to larger and higher methodological quality trials did not reduce 200 
the number of patient-reported outcomes identified. Thematic analysis of in-depth patient 201 
interviews identified five additional patient reported outcomes.  202 
 203 
Fetal outcomes 204 
Different methodological decisions resulted in differences in the number of fetal outcomes 205 
being identified (Figure S4). Considering the results of the systematic review, when no 206 
limitations were placed within the search strategy, inclusion criteria, or outcome extraction, 207 
eight fetal outcomes were identified. Limiting the search strategy reduced this to seven 208 
outcomes. When only primary outcomes were extracted from trial reports only three fetal 209 
outcomes were identified. Thematic analysis of in-depth patient interviews eclampsia 210 
identified six fetal outcomes. 211 
 212 
Neonatal outcomes 213 
The methodology used made a substantial difference in the number and diversity of neonatal 214 
outcomes identified (Figure 4). Considering the results of the systematic review, when no 215 
limitations were placed within the search strategy, inclusion criteria, or outcome extraction, 216 
25 neonatal outcomes were identified. Limiting the search strategy reduced this to between 217 
19 and 25 outcomes depending on the decision made. Important domains were not captured 218 
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by some strategies, especially when the search was limited to primary outcomes, including 219 
neurological morbidity, gastrointestinal morbidity, and infectious morbidity. Thematic analysis 220 
of in-depth patient interviews identified 14 neonatal outcomes, three domains, neurological, 221 
cardiovascular, and haematological morbidity, was not represented. 222 
 223 
Childhood outcomes 224 
The same six neurodevelopmental outcomes were identified when: (1) no limitations were 225 
placed within the search strategy, inclusion criteria, or outcome extraction; (2) the inclusion 226 
criteria was limited to larger trials; (3) the inclusion criteria was limited to higher 227 
methodological quality trial (Figure S5). An additional six outcomes, including growth, 228 
disability, and immune system disorders, were identified when in-depth interviews with 229 
women with lived experience of pre-eclampsia were thematically analysed. 230 
 231 
Resource utilisation outcomes 232 
Considering the results of the systematic review, when no limitations were placed within the 233 
search strategy, inclusion criteria, or outcome extraction, four resource utilisation outcomes 234 
were identified (Figure S6). Limiting the search strategy did not reduce the number of 235 
resource utilisation outcomes identified. When commonly reported outcomes were extracted 236 
from trial reports, only two resource utilisation outcomes were identified. When primary 237 
outcomes were extracted from trial reports, no recourse utilisation outcomes were identified. 238 











Main findings  247 
This study has demonstrated that different methodological decisions can make a substantial 248 
impact on the identification of potential core outcomes. Extracting outcomes from published 249 
pre-eclampsia trials was an effective way of identifying a range of maternal, fetal, and 250 
neonatal outcomes. However, limitations placed within the search strategy reduced the 251 
number and diversity of potential core outcomes identified, particularly for maternal and 252 
neonatal outcomes. Limiting the extraction of outcomes to primary outcomes or outcomes 253 
commonly reported in pre-eclampsia trials substantially reduced the number and diversity of 254 
potential core outcomes identified. Thematic analysis of in-depth interviews with women with 255 
lived experience of pre-eclampsia identified an additional 12 (10%) outcomes relating to their 256 
own wellbeing and the future health of their offspring. All outcomes will be entered into a 257 
Delphi survey to identify a core outcome set for pre-eclampsia. 258 
 259 
Strengths and limitations 260 
To our knowledge, this is the first study to objectively quantify the impacts of different 261 
methodological decisions on the identification of potential core outcomes. A diverse range of 262 
potential core outcomes, identified using quantitative and qualitative research, were 263 
successfully organised within a single taxonomy to ensure comparability. Descriptive tables 264 
were effective in demonstrating and quantifying the effect of different methodological 265 
decisions on the identification of potential core outcomes.  266 
 267 
Our empirical evaluation has several limitations. Methodological decisions evaluated within 268 
this study were identified by reviewing core outcome set development studies relevant to 269 
women’s health, applied to pre-eclampsia, and might be different in other topic areas. 270 
Further research is required to explore other methodological decisions and to confirm the 271 
findings of this study are applicable in other core outcome set development studies 272 
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standardising outcomes in other disease areas such as infertility, endometriosis, and 273 
preterm birth.21-23 The study did not evaluate the ease outcome collection, the quality of 274 
measurement of the outcome, or other relevant factors. Such an approach could have 275 
provided additional insight into the most appropriate methods to identify potential core 276 
outcomes. Future core outcome set developers should consider exploring these issues. 277 
 278 
Interpretation 279 
Previous core outcome set development studies have rarely discussed the impact of 280 
different methodological decisions on the development of a long list of potential core 281 
outcomes. An interim study published as part of the development of a core outcome set for 282 
preterm birth briefly discussed the potential impact of restricting the search strategy to 283 
recently published trials and only extracting primary outcomes from published preterm birth 284 
trials. The core outcome set developers noted the number and diversity of outcomes 285 
identified “may have been influenced” by these decisions.24 The findings of this study 286 
confirms that careful attention should be paid to the development of a long list of potential 287 
core outcomes.  288 
 289 
The need to develop core outcome sets in women’s health to address poorly chosen, 290 
collected, and reported outcomes has been demonstrated by several systematic reviews, in 291 
a diverse range of conditions including, endometriosis, twin-twin transfusion syndrome, and 292 
vaginal and pelvic organ prolapse.25-29 Unfortunately, there is potential to waste limited 293 
resources and introduce unnecessary delays in identifying a useful core outcome sets if 294 
inappropriate development methods are used. There is currently limited guidance regarding 295 
the development of a long list of potential core outcomes and the following specific 296 
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Recommendations for future core outcome set developers 301 
Both quantitative and qualitative research methods should be used in developing a long list 302 
of potential core outcomes. When undertaking a systematic review of published randomised 303 
trials to identify potential core outcomes, no limitations should be placed within the search 304 
strategy, inclusion criteria should be broad, and all outcomes should be extracted from trial 305 
reports. Restricting the extraction of outcomes from trial reports, including only extracting 306 
primary outcomes or commonly reported outcomes, is likely to decrease the number and 307 
diversity of potential core identified. 308 
 309 
Thematic analysis of in-depth interviews with patients was an effective strategy to ensure 310 
relevance to a broad range of stakeholders. It should be noted that less resource intensive 311 
data collection methods, including focus groups, observation, and free text questionnaires, 312 
secondary analysis of existing data, or meta-synthesis, have not been formally evaluated 313 
and could be useful alternative to in-depth interviews. Using qualitative research methods is 314 
important as outcomes reported in published research may not hold the same relevance for 315 
patients, particularly when published trials pre‐dates the recent emphasis on patient and 316 
public involvement in study design. 317 
 318 
Future core outcome set developers should carefully consider and draw upon the expertise 319 
of a range of stakeholders when considering different methods to identify a robust set of 320 
potential core outcomes. The specific methods, justification for their selection, and their 321 
potential impact on the final core outcome set should be explicitly discussed within interim 322 
publications and the final core outcome set publication. This approach should increase 323 
transparency, improve clarity, and reduce bias. 324 
 325 
Given the uncertainty in core outcome set development methods, further methodological 326 
research is required.  A research agenda should be embedded within future core outcome 327 
set development studies to address this uncertainty and strengthen the evidence base. 328 
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Priority should be given to the evaluation of development methods which have the potential 329 
to minimise bias, maximise efficiency, and increase implementation. Further research is 330 
needed to understand the relationship between potential core outcomes entered into a 331 
consensus development method and the core outcomes eventually identified. Is a 332 
comprehensive long list of potential core outcomes required to secure a final core outcome 333 
set relevant to key stakeholders? The modified Delphi method is commonly used to identify 334 
consensus ‘core’ outcomes and enables participants to suggest additional outcomes to be 335 
entered into the consensus development process. What is not known is whether outcomes 336 
suggested by participants within the consensus development process could address 337 
perceived deficiencies in the methods used to develop a long list of potential core outcomes 338 
or even making certain methods redundant. 339 
 340 
Conclusion 341 
Different methodological decisions have considerable impact on the number and diversity of 342 
potential core outcomes identified. When designing a systematic review to identify potential 343 
core outcomes, future core outcome set developers should use an extensive search 344 
strategy, pursue a broad inclusion criterion, and extract all outcomes from published trial 345 
reports. Qualitative research has an important role in ensuring the long list of potential core 346 
outcomes holds sufficient relevance to patients. Future core outcome set developers should 347 
implement this study’s recommendations to ensure comprehensive ascertainment of 348 
potential core outcomes. 349 
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